{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:28:02Z","timestamp":1793946482892,"version":"4.8.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303422"],"award-info":[{"award-number":["82303422"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105500","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T06:58:37Z","timestamp":1784789917000},"page":"105500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Reprogramming the vascular-immune niche: Towards a new therapeutic paradigm for glioblastoma"],"prefix":"10.1016","volume":"226","author":[{"given":"Wanwan","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guidong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4931-142X","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105500_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201436","article-title":"Investigating the interactions of glioma stem cells in the perivascular niche at single-cell resolution using a microfluidic tumor microenvironment model","volume":"9","author":"Adjei-Sowah","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105500_bib2","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1016\/j.cell.2024.09.018","article-title":"Pioneering discovery and therapeutics at the brain-vascular-immune interface","volume":"187","author":"Akassoglou","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105500_bib3","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1021\/acsbiomaterials.4c01039","article-title":"Investigation of folate-functionalized magnetic-gold nanoparticles based targeted drug delivery for liver: in vitro, in vivo and docking studies","volume":"10","author":"Alnasraui","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.critrevonc.2026.105500_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jcmm.14745","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in cancer","volume":"24","author":"An","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.trecan.2022.09.005","article-title":"Challenges in glioblastoma research: focus on the tumor microenvironment","volume":"9","author":"Bikfalvi","year":"2023","journal-title":"Trends Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008880","article-title":"Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival","volume":"12","author":"Bommareddy","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.7150\/thno.41692","article-title":"Glioma stem cells and their roles within the hypoxic tumor microenvironment","volume":"11","author":"Boyd","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib8","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noy015","article-title":"Hypoxia-activated evofosfamide for treatment of recurrent bevacizumab-refractory glioblastoma: a phase I surgical study","volume":"20","author":"Brenner","year":"2018","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.critrevonc.2026.105500_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13Ralpha2-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","article-title":"Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling","volume":"29","author":"Chen","year":"2022","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.critrevonc.2026.105500_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009492","article-title":"ALOX5 contributes to glioma progression by promoting 5-HETE-mediated immunosuppressive M2 polarization and PD-L1 expression of glioma-associated microglia\/macrophages","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib12","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/neuonc\/noac245","article-title":"ARL13B promotes angiogenesis and glioma growth by activating VEGFA-VEGFR2 signaling","volume":"25","author":"Chen","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","article-title":"Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity","volume":"40","author":"Chryplewicz","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105500_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ccell.2022.08.014","article-title":"Cancer cell autophagy, reprogrammed macrophages, and remodeled vasculature in glioblastoma triggers tumor immunity","volume":"40","author":"Chryplewicz","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105500_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2008.12.004","article-title":"PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF Treatment","volume":"15","author":"Crawford","year":"2009","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105500_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41467-023-44576-2","article-title":"Overcoming therapeutic resistance in oncolytic herpes virotherapy by targeting IGF2BP3-induced NETosis in malignant glioma","volume":"15","author":"Dai","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105500_bib17","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1158\/0008-5472.CAN-21-1456","article-title":"ALKBH5 facilitates hypoxia-induced paraspeckle assembly and il8 secretion to generate an immunosuppressive tumor microenvironment","volume":"81","author":"Dong","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005583","article-title":"Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib19","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1093\/neuonc\/noae177","article-title":"Intracranial administration of anti-PD-1 and anti-CTLA-4 immune checkpoint-blocking monoclonal antibodies in patients with recurrent high-grade glioma","volume":"26","author":"Duerinck","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn2231","article-title":"Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice","volume":"14","author":"Evgin","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib21","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.7150\/thno.82590","article-title":"SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages","volume":"13","author":"Fan","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105843","article-title":"The vascular-immune-neural network: a new pathophysiological paradigm and the dawn of cytoprotection in stroke","volume":"118","author":"Fang","year":"2025","journal-title":"eBioMedicine"},{"key":"10.1016\/j.critrevonc.2026.105500_bib23","first-page":"240","article-title":"TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma","volume":"22","author":"Fu","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib24","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1056\/NEJMoa2202028","article-title":"Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma","volume":"386","author":"Gallego Perez-Larraya","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141083","article-title":"SLIT2\/ROBO signaling in tumor-associated microglia and macrophages drives glioblastoma immunosuppression and vascular dysmorphia","volume":"131","author":"Geraldo","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105500_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/neuonc\/noae033","article-title":"Sexual-biased necroinflammation is revealed as a predictor of bevacizumab benefit in glioblastoma","volume":"26","author":"Hiller-Vallina","year":"2024","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib27","doi-asserted-by":"crossref","first-page":"eabm6340","DOI":"10.1126\/sciadv.abm6340","article-title":"Neural network learning defines glioblastoma features to be of neural crest perivascular or radial glia lineages","volume":"8","author":"Hu","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105500_bib28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri.2017.145","article-title":"Improving immune-vascular crosstalk for cancer immunotherapy","volume":"18","author":"Huang","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib29","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ccell.2025.05.017","article-title":"Bile acids activate cancer-associated fibroblasts and induce an immunosuppressive microenvironment in cholangiocarcinoma","volume":"43","author":"Huang","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105500_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2024.129446","article-title":"Investigation of dextran-coated magnetic nanoparticles encapsulated by medication and modified with folate for targeted drug delivery: Invitro and docking studies","volume":"321","author":"Hussein F Alnasraui","year":"2024","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.critrevonc.2026.105500_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147087","article-title":"Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects","volume":"133","author":"Jain","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105500_bib32","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.2147\/IJN.S467222","article-title":"Cancer Immunotherapy with \"Vascular-Immune\" crosstalk as entry point: associated mechanisms, therapeutic drugs and nano-delivery systems","volume":"19","author":"Jiang","year":"2024","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.critrevonc.2026.105500_bib33","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/1078-0432.CCR-23-0926","article-title":"Prognostic Markers of DNA methylation and next-generation sequencing in progressive glioblastoma from the EORTC-26101 trial","volume":"29","author":"Kessler","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.critrevonc.2026.105500_bib35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2023.11.032","article-title":"Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma","volume":"187","author":"Kirschenbaum","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105500_bib36","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s12276-020-00500-y","article-title":"Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity","volume":"52","author":"Lee","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib37","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.7150\/ijbs.113325","article-title":"Targeting the NAT10\/XIST\/YAP1 axis-mediated vascular abnormalization enhances immune checkpoint blockade in gastric cancer","volume":"21","author":"Lei","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105500_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122708","article-title":"Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy","volume":"311","author":"Li","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105500_bib39","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.7150\/thno.82975","article-title":"Ferritin light chain promotes the reprogramming of glioma immune microenvironment and facilitates glioma progression","volume":"13","author":"Li","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib40","doi-asserted-by":"crossref","first-page":"5223","DOI":"10.7150\/thno.84947","article-title":"Visualizing vasculature and its response to therapy in the tumor microenvironment","volume":"13","author":"Lin","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41586-023-06623-2","article-title":"Clinical trial links oncolytic immunoactivation to survival in glioblastoma","volume":"623","author":"Ling","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105500_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-025-03527-z","article-title":"Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. & Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib44","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s43018-020-00147-8","article-title":"Targeting PAK4 to reprogram the vascular microenvironment and improve CAR-T immunotherapy for glioblastoma","volume":"2","author":"Ma","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib45","article-title":"IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma","author":"Montoya","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.critrevonc.2026.105500_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202201888","article-title":"Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model","volume":"9","author":"Ngo","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105500_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41467-021-21407-w","article-title":"Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages","volume":"12","author":"Ochocka","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105500_bib48","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12943-021-01485-6","article-title":"EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3","volume":"21","author":"Pan","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib49","article-title":"Hypoxia-driven protease legumain promotes immunosuppression in glioblastoma","volume":"4","author":"Pang","year":"2023","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib50","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01731-z","article-title":"Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Pei","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib51","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/neuonc\/noaa062","article-title":"A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma","volume":"22","author":"Puduvalli","year":"2020","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.critrevonc.2026.105500_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12951-023-01997-x","article-title":"Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21\/SP1\/DNMT1 positive feedback loop","volume":"21","author":"Qiu","year":"2023","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2026.105500_bib53","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1158\/1078-0432.CCR-19-4110","article-title":"Anti-PD-1 Induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 Cytotoxic T Cells","volume":"26","author":"Rao","year":"2020","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114504","article-title":"Cancer-associated fibroblasts: origin, function, imaging, and therapeutic targeting","volume":"189","author":"Rimal","year":"2022","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2026.105500_bib55","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-022-02349-7","article-title":"Emerging therapies for glioblastoma: current state and future directions","volume":"41","author":"Rong","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","article-title":"A framework for advancing our understanding of cancer-associated fibroblasts","volume":"20","author":"Sahai","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib57","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105500_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jconrel.2024.03.042","article-title":"Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro","volume":"369","author":"Shamshiripour","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.critrevonc.2026.105500_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002181","article-title":"Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma","volume":"9","author":"Simonds","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib60","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1038\/s41467-024-46597-x","article-title":"Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR","volume":"15","author":"Spinelli","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105500_bib61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/CU9.0000000000000305","article-title":"Chimeric antigen receptor\u2013based cell therapy for treating urological tumors","volume":"19","author":"Tang","year":"2025","journal-title":"Curr. Urol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib62","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41591-022-01897-x","article-title":"Intratumoral oncolytic herpes virus G47\u2206 for residual or recurrent glioblastoma: a phase 2 trial","volume":"28","author":"Todo","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib63","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.22.00164","article-title":"NRG Oncology\/RTOG1205: A Randomized Phase II trial of concurrent bevacizumab and reirradiation versus Bevacizumab alone as treatment for recurrent glioblastoma","volume":"41","author":"Tsien","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13046-023-02640-1","article-title":"Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy","volume":"42","author":"Tu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib65","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","article-title":"Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer","volume":"23","author":"Unterleuthner","year":"2020","journal-title":"Angiogenesis"},{"key":"10.1016\/j.critrevonc.2026.105500_bib66","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/s41556-022-00918-8","article-title":"A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression","volume":"24","author":"Verginadis","year":"2022","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib67","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/s41591-021-01404-8","article-title":"Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis","volume":"27","author":"Vitanza","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03451-3","article-title":"Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial","author":"Vitanza","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib69","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.7150\/thno.55074","article-title":"FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts","volume":"11","author":"Wan","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib70","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1158\/0008-5472.CAN-23-3987","article-title":"Cancer-Associated Fibroblasts Expressing Sulfatase 1 Facilitate VEGFA-dependent microenvironmental remodeling to support colorectal cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib71","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s13046-019-1361-2","article-title":"Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1","volume":"38","author":"Wang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib72","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1016\/j.apsb.2023.09.005","article-title":"ACAT1 deficiency in myeloid cells promotes glioblastoma progression by enhancing the accumulation of myeloid-derived suppressor cells","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105500_bib73","article-title":"TS-2021, a third-generation oncolytic adenovirus that carried Ki67 promoter, TGF-\u03b22 5\u2032UTR, and IL\u221215 against experimental glioblastoma","volume":"96","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib74","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ymthe.2022.08.021","article-title":"CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105500_bib75","article-title":"An immunosuppressive vascular niche drives macrophage polarization and immunotherapy resistance in glioblastoma","volume":"10","author":"Yang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2026.105500_bib76","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/0008-5472.CAN-15-2973","article-title":"FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 Signaling","volume":"76","author":"Yang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq3558","article-title":"Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy","volume":"15","author":"Yang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105500_bib78","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1158\/1078-0432.CCR-22-3273","article-title":"Dual Role of CXCL8 in maintaining the mesenchymal state of glioblastoma stem cells and M2-Like Tumor-Associated Macrophages","volume":"29","author":"Yuan","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105500_bib79","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/neuonc\/noz189","article-title":"CCL5 of glioma-associated microglia\/macrophages regulates glioma migration and invasion via calcium-dependent matrix metalloproteinase 2","volume":"22","author":"Yu-Ju Wu","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006239","article-title":"IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM","volume":"11","author":"Zannikou","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105500_bib81","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bpa.12690","article-title":"Distribution and prognostic impact of microglia\/macrophage subpopulations in gliomas","volume":"29","author":"Zeiner","year":"2019","journal-title":"Brain Pathol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib82","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7150\/thno.74753","article-title":"Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105500_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/mt.2011.187","article-title":"Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 Glioma","volume":"20","author":"Zhang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105500_bib84","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41419-020-2696-5","article-title":"Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105500_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.111016","article-title":"Cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma","volume":"115","author":"Zhang","year":"2024","journal-title":"Cell. Signal."},{"key":"10.1016\/j.critrevonc.2026.105500_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111827","article-title":"CAF-mediated tumor vascularization: from mechanistic insights to targeted therapies","volume":"132","author":"Zhang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.critrevonc.2026.105500_bib87","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-020-00485-1","article-title":"Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells","volume":"10","author":"Zhang","year":"2020","journal-title":"Cell. & Biosci."},{"key":"10.1016\/j.critrevonc.2026.105500_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2023.109885","article-title":"Ki67-targeted oncolytic adenovirus expressing IL-15 improves intratumoral T cell infiltration and PD-L1 expression in glioblastoma","volume":"587","author":"Zhang","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.critrevonc.2026.105500_bib89","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13287-022-02968-z","article-title":"Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67\/IL-15 in GBM treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Stem Cell. Res. Ther."},{"key":"10.1016\/j.critrevonc.2026.105500_bib90","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.apsb.2020.09.014","article-title":"Manipulation of immune-vascular crosstalk: new strategies towards cancer treatment","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105500_bib91","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/neuonc\/noaa265","article-title":"Nestin+\/CD31+ cells in the hypoxic perivascular niche regulate glioblastoma chemoresistance by upregulating JAG1 and DLL4","volume":"23","author":"Zheng","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2026.105500_bib92","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41421-023-00529-z","article-title":"CD36(+) cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor","volume":"9","author":"Zhu","year":"2023","journal-title":"Cell. Discov."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:35:49Z","timestamp":1793943349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":92,"alternative-id":["S1040842826003872"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105500","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming the vascular-immune niche: Towards a new therapeutic paradigm for glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105500"}}